RS51011B - Prirodna antitela aktivna protiv hiv virusa - Google Patents

Prirodna antitela aktivna protiv hiv virusa

Info

Publication number
RS51011B
RS51011B YUP-701/03A YUP70103A RS51011B RS 51011 B RS51011 B RS 51011B YU P70103 A YUP70103 A YU P70103A RS 51011 B RS51011 B RS 51011B
Authority
RS
Serbia
Prior art keywords
active against
hiv virus
against hiv
natural antibodies
hiv
Prior art date
Application number
YUP-701/03A
Other languages
English (en)
Inventor
Radmila Metlas
Original Assignee
Diapharm, Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI20010500 external-priority patent/ITMI20010500A1/it
Priority claimed from IT2001MI002285A external-priority patent/ITMI20012285A1/it
Application filed by Diapharm, Limited filed Critical Diapharm, Limited
Publication of YU70103A publication Critical patent/YU70103A/sh
Publication of RS51011B publication Critical patent/RS51011B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Upotreba humanih antitela protiv ukupne frakcije humanog IgG, naznačena time što su pomenuta humana antitela dobijena afinitetnom hromatografijom seruma poreklom od normalnih individua koje nisu - inficirane sa HIV, koristeći smole vezane za ukupnu frakciju humanog IgG i što su sposobna da neutralizuju HIV-1, za pripremanje medikamenta za pasivnu imunoterapiju HIV-1 infekcija.
YUP-701/03A 2001-03-09 2002-03-06 Prirodna antitela aktivna protiv hiv virusa RS51011B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI20010500 ITMI20010500A1 (it) 2001-03-09 2001-03-09 Auto-anticorpi naturali e il loro uso nella terapia di malattie da virus dell'immunodeficienza umana
IT2001MI002285A ITMI20012285A1 (it) 2001-10-31 2001-10-31 Anticorpi naturali attivi contro il virus hiv

Publications (2)

Publication Number Publication Date
YU70103A YU70103A (sh) 2006-05-25
RS51011B true RS51011B (sr) 2010-10-31

Family

ID=26332768

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-701/03A RS51011B (sr) 2001-03-09 2002-03-06 Prirodna antitela aktivna protiv hiv virusa

Country Status (28)

Country Link
US (2) US20040106771A1 (sr)
EP (1) EP1366080B1 (sr)
JP (1) JP4601252B2 (sr)
KR (1) KR100871455B1 (sr)
CN (1) CN1494554A (sr)
AP (1) AP2003002852A0 (sr)
AT (1) ATE346870T1 (sr)
AU (1) AU2002257620B2 (sr)
BR (1) BR0207931A (sr)
CA (1) CA2440131A1 (sr)
CY (1) CY1108852T1 (sr)
CZ (1) CZ20032418A3 (sr)
DE (1) DE60216422T2 (sr)
DK (1) DK1366080T3 (sr)
EE (1) EE200300377A (sr)
ES (1) ES2278022T3 (sr)
HR (1) HRP20030701A2 (sr)
HU (1) HUP0303423A3 (sr)
IL (2) IL157753A0 (sr)
MX (1) MXPA03007976A (sr)
NO (1) NO20033934L (sr)
PL (1) PL366785A1 (sr)
PT (1) PT1366080E (sr)
RS (1) RS51011B (sr)
RU (1) RU2003125554A (sr)
SI (1) SI1366080T1 (sr)
TN (1) TNSN03066A1 (sr)
WO (1) WO2002072637A1 (sr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100330102A1 (en) 2009-06-26 2010-12-30 Wezen Biopharmaceuticals Srl A Socio Unico Immunoglobulin preparation for the treatment of hiv-1 infection

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639513A (en) * 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
US5788687A (en) * 1994-02-01 1998-08-04 Caphco, Inc Compositions and devices for controlled release of active ingredients
US5982866A (en) * 1997-04-25 1999-11-09 At&T Corporation Method and apparatus for forwarding caller identification for a credit card or calling card call to an automatic number identification system of a telephone network
DE19815430B4 (de) * 1998-04-07 2005-12-15 T-Mobile Deutschland Gmbh Verfahren zum Verbindungsaufbau von einem Mobilfunknetz zu einer Zielrufnummer eines privaten Kommunikationsnetzes
ES2527915T3 (es) * 1998-06-09 2015-02-02 Csl Behring Ag Producto de inmunoglobulina G (IgG) líquido
ES2684505T3 (es) * 1999-06-14 2018-10-03 Blackberry Corporation Método y aparato para comunicar a través de extensiones telefónicas de oficina virtual
US6818247B1 (en) * 2000-03-31 2004-11-16 Advanced Cardiovascular Systems, Inc. Ethylene vinyl alcohol-dimethyl acetamide composition and a method of coating a stent
US6970719B1 (en) * 2000-06-15 2005-11-29 Sprint Spectrum L.P. Private wireless network integrated with public wireless network
US7336668B2 (en) * 2001-09-24 2008-02-26 Christopher Lyle Adams Communication management system with line status notification for key switch emulation
US8040873B2 (en) * 2001-11-07 2011-10-18 Alcatel Lucent Distributed integration of legacy PBX system with SIP networks
US20030105799A1 (en) * 2001-12-03 2003-06-05 Avaz Networks, Inc. Distributed processing architecture with scalable processing layers
US7546143B2 (en) * 2001-12-18 2009-06-09 Fuji Xerox Co., Ltd. Multi-channel quiet calls
US7146163B2 (en) * 2002-10-01 2006-12-05 Isp Operator Corporation Sender-address-based telecommunications operator callback system and method
US20040086093A1 (en) * 2002-10-29 2004-05-06 Schranz Paul Steven VoIP security monitoring & alarm system
US7904068B2 (en) * 2003-06-06 2011-03-08 At&T Intellectual Property I, L.P. System and method for providing integrated voice and data services utilizing wired cordless access with unlicensed spectrum and wired access with licensed spectrum
US7715413B2 (en) * 2003-10-23 2010-05-11 Emerj, Inc. Multi-network exchange system for telephony applications
ATE527788T1 (de) * 2004-01-14 2011-10-15 Research In Motion Ltd System und verfahren zur drahtlosen provisionierung eines mobilkommunikationsgeräts
US8254989B2 (en) * 2004-07-29 2012-08-28 Sprint Spectrum L.P. Method and system for account balance restriction on application of cellular-PBX integration service
CA2550721A1 (en) * 2005-06-22 2006-12-22 Newstep Networks, Inc. Method and system for a communications session join function to facilitate the provision of enhanced communications services
US20070091907A1 (en) * 2005-10-03 2007-04-26 Varad Seshadri Secured media communication across enterprise gateway

Also Published As

Publication number Publication date
AU2002257620B2 (en) 2007-09-13
DE60216422D1 (de) 2007-01-11
DK1366080T3 (da) 2007-03-26
KR100871455B1 (ko) 2008-12-03
CZ20032418A3 (cs) 2004-02-18
US20040106771A1 (en) 2004-06-03
US20070020290A1 (en) 2007-01-25
IL157753A0 (en) 2004-03-28
MXPA03007976A (es) 2004-10-15
WO2002072637A1 (en) 2002-09-19
HUP0303423A2 (hu) 2004-01-28
JP2004532198A (ja) 2004-10-21
DE60216422T2 (de) 2007-11-29
KR20040000401A (ko) 2004-01-03
TNSN03066A1 (en) 2005-12-23
YU70103A (sh) 2006-05-25
PT1366080E (pt) 2007-03-30
IL157753A (en) 2010-04-29
CY1108852T1 (el) 2014-07-02
EP1366080B1 (en) 2006-11-29
ATE346870T1 (de) 2006-12-15
EE200300377A (et) 2003-10-15
NO20033934D0 (no) 2003-09-05
NO20033934L (no) 2003-11-06
SI1366080T1 (sl) 2007-06-30
EP1366080A1 (en) 2003-12-03
HRP20030701A2 (en) 2006-06-30
CA2440131A1 (en) 2002-09-19
CN1494554A (zh) 2004-05-05
ES2278022T3 (es) 2007-08-01
RU2003125554A (ru) 2005-02-10
AP2003002852A0 (en) 2003-09-06
HUP0303423A3 (en) 2005-11-28
JP4601252B2 (ja) 2010-12-22
BR0207931A (pt) 2004-03-02
PL366785A1 (en) 2005-02-07

Similar Documents

Publication Publication Date Title
ATE513563T1 (de) Therapeutische und toleranz-induzierende antikörper
CR8698A (es) Anticuerpos monoclonales al factor de crecimiento de hepatocito
NO20054170L (no) Antistoff mot human IL-21 reseptor og anvendelser derav
ATE471946T1 (de) Humanisierter antikörper (h14.18) des maus antikörpers 14.18, der gd2 bindet und seine fusion mit il-2
AR057807A1 (es) Formulaciones de anticuerpo anti-cd3
UA90457C2 (ru) Человеческое моноклональное антитело, которое специфически связывается с м-csf человека и блокирует связывание м-csf с с-fms
MA40041A (fr) Anticorps anti-gitr et leurs procédés d'utilisation
BR0215050A (pt) Compostos heterocìclicos de ligação a receptor de quimiocina com eficácia realçada
EA201000424A1 (ru) Антитела к il-23
EA200970469A1 (ru) Антитела-агонисты рецептора trkb и их применение
HRP20060033B1 (hr) Humana anti-ngf neutralizirajuä†a antitijela kao selektivni inhibitori ngf rute
HRP20240240T1 (hr) Protutijela anti-pd-l1 i njihova uporaba za poboljšanje funkcije t-stanice
EA201100694A1 (ru) Антитело к cd38 человека и его применение
BR0209689A (pt) Uso de fragmento de hmg como agente anti-inflamatório
UA109633C2 (uk) Антитіло людини проти тканинного фактора
MX2021004779A (es) Anticuerpos cd47 novedosos y metodos para usarlos.
BR0314038A (pt) Anticorpo humano isolado, método de tratar uma doença mediada com il-1 em um paciente, composição farmacêutica, cadeias pesada e leve, e, método de mapeamento de epitopo de um antìgeno selecionado
UA112743C2 (uk) Терапевтичний dll4-зв'язувальний білок
MX338195B (es) Preparaciones de anticuerpos.
EA200970586A1 (ru) Антитела к цитомегаловирусу человека (hcmv)
DK1200126T3 (da) Anvendelse af CD28-specifikke monoklonale antistoffer til fremstilling af en farmaceutisk sammensætning til behandling af virusinfektioner
NO20024223D0 (no) Monoklane antistoffer til den humane LDL-reseptor, deres fremstilling og anvendelse
ITRM20040586A1 (it) Epitopi antigenici dell'interleuchina-21, anticorpi relativi e loro uso in campo medico.
MX2010009640A (es) Uso de conjugados de interleucina-1 en el tratamiento de diabetes.
Andersson et al. Effects on mouse immunity of long‐term exposure in vivo to minute amounts of HEMA